Sign in

You're signed outSign in or to get full access.

Vanessa O. Chambers

Director at UWHARRIE CAPITAL
Board

About Vanessa O. Chambers

Vanessa O. Chambers (age 71) is an independent director of Uwharrie Capital Corp, first elected in 2022; she serves concurrently on the subsidiary Uwharrie Bank board . Her background spans community ministry and healthcare operations, including administrator roles at assisted living facilities, CNA/Med Tech certifications, a 2019 Diploma in Biblical Studies, and a 2002 Certificate in Business Administration – HR Management; she also owns an event planning business and has experience in small business management .

Past Roles

OrganizationRoleTenureCommittees/Impact
Carebridge Assisted Living; America Living Centers; Willow Ridge Assisted Living (Albemarle, NC)AdministratorPrior years (dates not specified)Healthcare operations leadership
Various assisted living facilities in Albemarle (Britthaven, Woodhaven Court, Spring Arbor)Healthcare professional/administrator capacitiesPrior years (dates not specified)Resident care and facility management
Family care home (New London, NC)Co‑Owner, Administrator, Marketing DirectorPrior years (dates not specified)Small business management and marketing
In‑home private duty CNACertified Nursing AssistantCurrentPatient care; CNA I/II and Med Tech; CPR; Preceptor certification (2019)

External Roles

OrganizationRoleTenureNotes
Uwharrie Bank (subsidiary)DirectorConcurrent with Uwharrie Capital board serviceAll Company directors also serve as Uwharrie Bank directors
Ministry workCommunity Outreach Advocate and MinisterOngoingFaith-based community engagement

Board Governance

  • Independence: The Board determined Ms. Chambers is “independent” under NASDAQ listing standards and Exchange Act rules; she is not among directors flagged as non‑independent under SEC Rule 10A‑3(b) .
  • Committee assignments: In 2024–2025, the full Board served as the Human Resources & Compensation Committee and the Nominating Committee, so she participated on both; she is not listed on the Audit Committee .
  • Audit Committee cadence: Audit Committee met four times in 2024 and five times in 2023; Ms. Chambers was not a member .
  • Attendance: The Board held twelve regular meetings in 2024; each director attended ≥75% of Board and applicable committee meetings; 16 of 17 directors attended the 2024 annual shareholder meeting (individual attendance not specified) .
  • Leadership: Chair and Vice Chair roles rotate; the CEO is not a director, supporting independent oversight and risk committee structures (ERM, IT Steering, Credit Committee) reporting up to Audit Committee/Board .

Fixed Compensation

YearFees Earned or Paid in CashStock Awards (Fair Value)Option AwardsAll OtherTotal
2023$10,200 $2,987 $13,187
2024$9,700 $2,995 $12,695
  • Structure: Directors received $725 per Board meeting; $100 per non‑Audit committee meeting; Audit Committee members received $500 per Audit meeting plus $100 per hour beyond three hours (Ms. Chambers not on Audit Committee) .
  • Annual retainer: $4,000 semi‑annual—$3,000 in Company common stock and $1,000 in cash; additional $7,500 monthly retainer for Board Chair/Vice Chair and Audit Chair (not applicable to Ms. Chambers) .

Performance Compensation

ComponentDetailDates/SharesValuation
Equity retainer (2023)Semi‑annual common stock grants189 shares (June 2023); 181 shares (Dec 2023) Aggregate fair value $2,987
Equity retainer (2024)Semi‑annual common stock grants193 shares (June 2024); 178 shares (Dec 2024) Aggregate fair value $2,995
  • No options or performance share units are awarded to directors; director pay is a mix of meeting fees and fixed equity/cash retainer without disclosed performance metrics or formulaic targets for directors .

Other Directorships & Interlocks

CategoryDetail
Public company boardsNone in last five years for any director; no investment company directorships
Internal interlocksServes on Uwharrie Bank board as all Company directors do
Notable external boardsNot disclosed for Ms. Chambers

Expertise & Qualifications

  • Healthcare operations and elder care administration; licensed Med Tech; CNA I/II; CPR; Preceptor certification (2019) .
  • Community ministry and outreach; small business management including event planning .
  • Education: Diploma in Biblical Studies (2019); Certificate in Business Administration – HR Management (2002) .

Equity Ownership

Metric20242025
Shares beneficially owned1,811 2,222
Ownership % of outstanding<1% <1%
Nature of ownershipShared voting/investment power for all reported shares
Options (exercisable/unexercisable)None; no stock options held by identified individuals
Pledged sharesNot disclosed

Governance Assessment

  • Strengths: Independent status; participation on full‑Board Compensation and Nominating committees; adequate attendance thresholds met; fixed, modest director pay with transparent equity retainer mechanics; no public‑company interlocks or related‑party exposures disclosed for Ms. Chambers .
  • Alignment: Equity retainer creates baseline ownership, with shares increasing from 1,811 (2024) to 2,222 (2025), though still <1% of outstanding; options are not used, limiting risk‑taking incentives .
  • Oversight environment: Audit Committee designated financial expert and recurring meetings; CEO not on board; ERM/IT/Credit committees provide structured risk reporting to Audit/Board, bolstering controls even for non‑Audit committee directors .
  • RED FLAGS:
    • Hedging policy: Company has not adopted a formal hedging prohibition for directors/employees; while an insider trading policy exists, the absence of an explicit anti‑hedging policy is shareholder‑unfriendly relative to best practice .
    • Disclosure gaps: No director‑specific stock ownership guideline amounts or compliance status disclosed; individual annual meeting attendance not specified .
  • Net view: For investors, Ms. Chambers’ independence, improving share ownership, and committee participation support baseline governance quality; lack of explicit anti‑hedging policy and limited disclosure on ownership guideline compliance modestly detract from confidence, though no direct conflicts or related‑party transactions involving her are disclosed .